Tech Company Financing Transactions
Sub-Q Bionics Funding Round
On 3/31/2026, Sub-Q Bionics secured $1.5 million in Seed funding from Israel Innovation Authority, Mayo Clinic and private investors.
Transaction Overview
Company Name
Announced On
3/31/2026
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Seed
Proceeds Purpose
The funding will enable Sub-Q Bionics to continue to develop its novel bionic lymph node technology designed to transform how lymphedema is managed, based on scientific innovations from the Weizmann Institute and Shamir Medical Center.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3374 Pete Miller Ln N
Stillwater, MN 55082
USA
Stillwater, MN 55082
USA
Phone
Undisclosed
Website
Email Address
Overview
Our company aims to transform lymphedema treatment for women with a groundbreaking implant technology allowing for seamless integration into patients' lives, thus increasing patient satisfaction, compliance and quality of life. For lymphedema patients who cannot tolerate daily compression therapy, our first-in-class implant will provide continuous fluid management without daily intervention, allowing people to return to normal activities that would otherwise be impossible with an external device.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Tom Sudow
Chief Executive Officer
Jordan Pollack
Chief Financial Officer
Gregg Pollack
Chief Technical Officer
David Knapp
VP - Marketing
Rachel Offenburg
Browse more venture capital transactions:
Prev: 3/31/2026: Test of Things venture capital transaction
Next: 3/31/2026: Saronic Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs